Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Moph: Prevention Guidance following the Storm Repercussions

 
The Information office of the Ministry of Public Health issued the following statement:

In anticipation of the upcoming storms that will hit Lebanon, and in the light of its awareness-raising tasks, the Ministry of Public Health issued the following guidelines to ensure the safety of the citizens.
  • Follow the safety standards while using heating appliances, in particular at night to prevent any gas leak or fire.
  • Equip your houses with fire extinguishers.
  • Avoid moving between cold and hot areas and drink plenty of fluids to prevent dehydration.
  • People with heart diseases, asthma or obstructive pulmonary are advised not to leave home to avoid exposure to cold air that might cause health problems.
  • Store sufficient quantities of medicines for all the period of the storm.
For more information on the protection from accidents caused by heating appliances, read the following guidelines on children protection.
 
Heating:
  • When using an electric heater, check the electric cables to avoid any electrical fire
  • When using a gas heater, check the gas hose for any gas leak
  • When using  coal – wood – diesel heaters, the following should be considered:
 
  • Don’t allow children to contact or play with the flame to prevent burns, accidents and suffocation
  • Equip your houses with fire extinguishers, fire blanket and  a smoke detector (if possible)
  • Keep the heater far from diesel tanks
  • Ensure flammable items are kept away from the heating appliances (curtains, blankets…)
  • Don’t keep the clothes close to heating appliances to dry them 
Personal prevention tips:
  • Avoid exposing your back and neck to cold air and wear suitable clothes
  • Avoid moving between cold and hot areas
  • Drink plenty of water and fluids to prevent dehydration
  • Turn off your home’s electricity in the event of flooded home 
People with chronic diseases:
  • People with asthma or obstructive pulmonary are advised not to leave home during the storm
  • People with heart diseases are advised to stay home since cold air can cause vessels/ coronary arteries to narrow, which can lead to a pain in the chest
  • Store sufficient quantities of medicines for all the period of the storm. 
Tips for children

Clothing:
  • Dress your infants and children in warm clothes, in particular when going outside. Don’t forget winter accessories such as gloves and hat. Dress babies and young children in one more layer of clothing than an adult would wear in the same conditions.
  • blankets, quilts, pillows can cause Sudden Infant death syndrome 
  • Hypothermia
  • Hypothermia is a drop in body temperature caused by exposure to cold temperatures. It usually occurs when children play outside in extremely cold weather without wearing appropriate clothes or when clothes are wet.
  • Symptoms are shivering, mumbling, very low energy and even loss of consciousness. In such a case, bring the child indoors, remove any wet clothes, wrap with blanket or warm clothes and contact the doctor if need be. 
Frostbite
Frostbite occurs when cold causes extremities to freeze, such as fingers, feet, ears and nose which may become white or blue, or may itch or burn.

In case of frostbite, the child should be brought indoors and his injured parts should be put in warn water. Warm towels can also be applied to nose, ears and lips. Do not to rub the frozen area surfaces. A few minutes later, give the child warm fluids to drink. If numbness persisted more than a couple of minutes, contact your doctor.
 
    ...
    7
    ...
ATC Name B/G Ingredients Dosage Form Price
J02AX05 MYCAMINE B Micafungin (sodium) - 50mg 50mg Injectable lyophilised powder for solution 13,170,341 L.L
J02AX05 MEGMENTO G Micafungin (sodium) - 50mg 50mg Injectable powder for solution 9,530,364 L.L
J02AX05 MEGMENTO G Micafungin (sodium) - 100mg 100mg Injectable powder for solution 17,158,569 L.L
J07AH MENFIVE G Meningococcal (serogroups A, C, Y, W, X) Polysaccharide conjugate vaccine - Injectable freeze dried powder + diluent 3,527,587 L.L
J07AH08 MENACTRA MENINGOCOCCAL POLYSACCHARIDE DIPHTERIA TOXOID CONJUGATE VACCINE B Meningococcal Polysaccharides (serogroups A, C, Y and W-135) - 4mcg/0.5ml each, Diphteria Toxoid Protein - 48mcg/0.5ml Injectable solution 6,144,048 L.L
J07AH08 MENQUADFI G Meningococcal (serogroups A, C, W and Y) conjugate vaccine - Injectable solution 4,859,334 L.L
J07BD52 M-M-R II (MEASLES, MUMPS AND RUBELLA VIRUS VACCINE LIVE) B Rubella virus live attenuated - , Mumps virus live attenuated - , Measles virus live attenuated - Injectable solution+diluent 12,924,401 L.L
J07BD52 MEASLES, MUMPS AND RUBELLA VACCINE LIVE ATTENUATED (FREEZE-DRIED) MMR G Rubella virus live attenuated - ?1000CCID50 /0.5ml, Mumps virus live attenuated - ?5000CCID50 /0.5ml, Measles virus live attenuated - ?1000CCID50 /0.5ml Injectable freeze dried powder + diluent 739,113 L.L
L01BA01 METHOTREXAT EBEWE G Methotrexate - 500mg 500mg Injectable solution 1,842,408 L.L
L01BB04 MAVENCLAD B Cladribine - 10mg 10mg Tablet 182,343,396 L.L
L01DB07 MITOXANTRON EBEWE G Mitoxantrone - 20mg/10ml 20mg/10ml Injectable concentrated solution 11,064,120 L.L
L01EB02 MIRATA G Erlotinib (HCl) - 100mg 100mg Tablet, film coated 77,379,009 L.L
L01EB02 MIRATA G Erlotinib (HCl) - 150mg 150mg Tablet, film coated 88,599,923 L.L
L01FA01 MABTHERA BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrated solution 35,722,424 L.L
L01FA01 MABIXEN 100 BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrate for solution 22,183,393 L.L
L01FA01 MABIXEN 100 BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrate for solution 11,091,696 L.L
L01FA01 MABTHERA BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrated solution 80,211,932 L.L
L01FA01 MABIXEN 500 BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 136,761,210 L.L
L01FA01 MABIXEN 500 BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 74,718,320 L.L
L01FD01 MABTIN 440 BioTech Trastuzumab (r-DNA origin) - 440mg 440mg Injectable powder for solution 70,042,700 L.L
L01FG01 MVASI BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable concentrate for solution 58,035,926 L.L
L01FG01 MVASI BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable concentrate for solution 17,173,671 L.L
L01FX02 MYLOTARG BioTech Gemtuzumab Ozogamicin - 4.5mg 4.5mg Injectable powder 748,160,090 L.L
L03AX16 MOZOBIL B Plerixafor - 20mg/ml 20mg/ml Injectable solution 413,801,327 L.L
L04AA06 MYFORTIC B Mycophenolic acid (sodium) - 360mg 360mg Tablet, gastroresistant 17,836,325 L.L
L04AA06 MMF G Mycophenolate mofetil - 500mg 500mg Tablet, coated 4,087,969 L.L
L04AA42 MAYZENT B Siponimod - 0.25mg 0.25mg Tablet, film coated 15,102,158 L.L
L04AA42 MAYZENT B Siponimod - 0.25mg 0.25mg Tablet, film coated 124,258,444 L.L
L04AA42 MAYZENT B Siponimod - 2mg 2mg Tablet, film coated 124,258,444 L.L
L04AX03 METOJECT G Methotrexate disodium - 10mg/0.2ml 10mg/0.2ml Injectable solution 1,553,482 L.L
    ...
    7
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025